JOANN MAHAN: Open Payments
NPI 1104225317 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 45 payments from 13 companies in 2025. Trend: 2023 $2,099 · 2024 $258 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 12 | $223 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $132 |
| Teva Pharmaceuticals USA, Inc. | 5 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $100 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| Valinor Pharma, LLC | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Tonix Medicines, Inc. | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
Products named: NUZYRA, RELISTOR, AUSTEDO XR, CAPLYTA, Belbuca, MOVANTIK, REXULTI, TONMYA.
Industry payments across AR — which companies pay providers there.
